Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for Co-occurring AUD and PTSD
NCT04523922Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Mar 2021
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin nasal spray in alcohol use disorder (AUD), post-traumatic stress disorder (PTSD), sponsored by Medical University of South Carolina. Started Mar 2021; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol use disorder (AUD)post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT04523922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04523922.